T80.3XXA ABO incompatibility reaction, initial encounter

Name of the Condition

• ABO incompatibility reaction, initial encounter.

Summary

This condition describes an adverse immune reaction occurring during the initial encounter when blood or blood products with incompatible ABO antigens are transfused. It is a serious complication that can lead to hemolysis, organ damage, and systemic effects. The reaction is driven by pre-existing antibodies in the recipient that target antigens on the transfused red blood cells.

Causes

ABO incompatibility reactions result from the transfusion of blood or blood products containing ABO antigens that do not match the recipient's blood type. This mismatch triggers an immune response, where the recipient's antibodies bind to the donor red blood cells, leading to their destruction (hemolysis). The reaction can occur with red blood cells, plasma, or platelets if ABO compatibility is not maintained.

Risk Factors

• Transfusion of blood products without proper ABO typing or crossmatching
• Emergency transfusions where typing may be delayed
• Human error in blood product labeling or administration
• Use of pooled plasma products with mixed ABO types
• Transfusion of platelets or plasma from donors with incompatible ABO antigens

Symptoms

• Fever, chills, or rigors
• Flank pain or back pain
• Hemoglobinuria (dark urine)
• Hypotension or tachycardia
• Dyspnea or respiratory distress
• Jaundice or pallor
• Nausea, vomiting, or abdominal pain

Diagnosis

Diagnosis involves clinical assessment of symptoms, laboratory testing for hemolysis (e.g., elevated bilirubin, decreased haptoglobin, hemoglobinuria), and confirmation of ABO incompatibility through blood typing and crossmatching. Additional tests may include direct antiglobulin testing (Coombs test) to detect antibody-coated red blood cells.

Treatment Options

Treatment focuses on stopping the transfusion immediately, providing supportive care (e.g., fluids, oxygen), and managing hemolysis or organ dysfunction. Interventions may include diuretics for renal protection, vasopressors for hypotension, and monitoring for complications like disseminated intravascular coagulation (DIC).

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and promptness of treatment. Mild cases may resolve with supportive care, while severe reactions can lead to organ failure or death. Follow-up includes monitoring for delayed complications (e.g., renal impairment) and ensuring proper blood compatibility for future transfusions.

Complications

• Acute kidney injury or renal failure
• Disseminated intravascular coagulation (DIC)
• Shock or hemodynamic instability
• Respiratory distress or acute lung injury
• Neurological complications (e.g., stroke)

Lifestyle & Prevention

Prevention relies on strict adherence to blood typing, crossmatching, and verification protocols before transfusion. Healthcare providers should use barcode scanning, double-check systems, and train staff on error prevention. Patients with known antibodies may require specialized blood products.

When to Seek Professional Help

Seek immediate medical attention if symptoms of transfusion reaction occur, such as fever, chills, pain, or changes in urine color. Delayed reactions (e.g., jaundice) should also prompt evaluation to rule out ongoing hemolysis or organ damage.

Tips for Medical Coders

Document the initial encounter and specify the reaction type (e.g., hemolytic) if available. Include details on transfusion context, timing, and clinical findings to support code assignment. Ensure documentation aligns with the "initial encounter" designation for accurate coding.